RxDoctor Payments Data

Maia Greene

Nurse Practitioner · Edison, NJNPI 1154533511

Payments from drug & device makers

$1,935in general payments, 2019–2025

Across 118 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$342
  • Bayer$327
  • Novo Nordisk$296
  • AstraZeneca$150
  • Lilly USA, LLC$145
  • Abbott$142
  • plus $533 from 14 others

What the payments were for

  • Food & beverage$1,935100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,935 in reported general payments places this provider in the 85th percentile of 2,138 nurse practitioner providers in New Jersey.

See all nurse practitioner providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin38$41,519
OzempicSemaglutide14$22,757
Atorvastatin Calcium96$1,288
Albuterol Sulfate HfaAlbuterol Sulfate35$917
Diclofenac Sodium12$766
Omeprazole28$602
Ezetimibe48$499
Fluticasone Propionate40$481
Gabapentin23$389
Rosuvastatin Calcium18$342
Nateglinide11$299
Metoprolol Succinate25$270
Levothyroxine Sodium29$257
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$242
Metformin Hcl40$229

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$296$22,75714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,138 nurse practitioner providers in New Jersey.

Other nurse practitioner in Edison

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →